Skip to Main Content

Author Details

Yash B Joshi
University of California San Diego School of Medicine, and Clinical Center
2011
59
22
PMIDPaper TitleJournal TitlePublished Year
37683728Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species.Biol Psychiatry Cogn Neurosci Neuroimaging2024
36198769Retraction Note to: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.Mol Psychiatry2023
37908092Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh.Am J Psychiatry2023
37594223Reporting Rigor of Cancer Rehabilitation Interventions: Application of the CReDECI-2 Guidelines.Am J Phys Med Rehabil2023
37406367Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders.Psychiatry Res2023
36404550Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease.J Alzheimers Dis2023
36441495Cholinergic Functioning, Cognition, and Anticholinergic Medication Burden in Schizophrenia.Curr Top Behav Neurosci2023
34187732The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia.Schizophr Res2022
32658511Contextualizing the road to recovery: A novel method of assessing outcome trajectories in clinical trials.Psychol Serv2021
33493776Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.Schizophr Res2021
33780847Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia.Schizophr Res2021
34500174Central auditory processing deficits in schizophrenia: Effects of auditory-based cognitive training.Schizophr Res2021
34673326Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.Psychiatry Res2021
34690144Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.J Alzheimers Dis2021
33985348Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.Am J Psychiatry2021
33340619Neural network dynamics underlying gamma synchronization deficits in schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry2021
33453303Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjects.Int J Psychophysiol2021
33470494Source decomposition of the frontocentral auditory steady-state gamma band response in schizophrenia patients and healthy subjects.Psychiatry Clin Neurosci2021
32856089Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia.Schizophr Bull2021
32340927Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia.Biol Psychiatry Cogn Neurosci Neuroimaging2020
31744751Deviation from expected cognitive ability is a core cognitive feature of schizophrenia related to neurophysiologic, clinical and psychosocial functioning.Schizophr Res2020
31759809Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients.Schizophr Res2020
33110410Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia.Front Psychiatry2020
33329160Neurophysiologic Characterization of Resting State Connectivity Abnormalities in Schizophrenia Patients.Front Psychiatry2020
33230190Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia.Transl Psychiatry2020
32830097Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia.Biol Psychiatry Cogn Neurosci Neuroimaging2020
32829382A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients.Neuropsychopharmacology2020
32961542Memantine effects on auditory discrimination and training in schizophrenia patients.Neuropsychopharmacology2020
32947448Conceptualizations of Mental Disorder at a US Academic Medical Center.J Nerv Ment Dis2020
30660574Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia.Schizophr Res2019
30738698Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients.Schizophr Res2019
30377381Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.Neuropsychopharmacology2019
30586570Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.Int J Psychophysiol2019
28927552Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia.Schizophr Res2018
30055883Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care.Schizophr Res2018
29929773Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia.Schizophr Res2018
30510520Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia.Front Psychiatry2018
28614159Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report.J Clin Psychopharmacol2017
28425497Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.Neuropsychopharmacology2017
26077691Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice.Mol Psychiatry2016
27043124Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.J Clin Psychopharmacol2016
25052851Gamma secretase-activating protein is a substrate for caspase-3: implications for Alzheimer's disease.Biol Psychiatry2015
25708815The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease.Trends Pharmacol Sci2015
25642165The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype.Front Cell Neurosci2015
23478745Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.Mol Psychiatry2014
25122659Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer's disease.Hum Mol Genet2014
24868318Lipid peroxidation in psychiatric illness: overview of clinical evidence.Oxid Med Cell Longev2014
24629673Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles.Neurobiol Aging2014
24332986Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase.Neurobiol Aging2014
24300237Overexpression of 12/15-lipoxygenase increases anxiety behavior in female mice.Neurobiol Aging2014
  • 1 - 50 of 59

Recommended Authors

European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2009
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2004
Number of shared co-authors 5
Harvard Medical School VA Boston HealthCare System.
Career Start Year 2004
Number of shared co-authors 0
Universidade Federal de Sao Paulo (UNIFESP), Brazil Instituto #amesuamente.
Career Start Year 1998
Number of shared co-authors 4
University Hospital Frankfurt am Main
Career Start Year 1998
Number of shared co-authors 3
University of California Irvine
Career Start Year 1998
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Oslo University Hospital & Institute of Clinical Medicine, University of Oslo
Career Start Year 1994
Number of shared co-authors 5
Stanford University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 0
Campbell Family Mental Health Research Institute
Career Start Year 1990
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1988
Number of shared co-authors 0
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 0
Stanford University
Career Start Year 1988
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 1987
Number of shared co-authors 2
Janssen Medical Ltd
Career Start Year 1986
Number of shared co-authors 0
Indiana University School of Medicine
Career Start Year 1986
Number of shared co-authors 1
Ludwig-Maximilians-Universitat Munchen.
Career Start Year 1986
Number of shared co-authors 3
Banner Alzheimer's Institute
Career Start Year 1984
Number of shared co-authors 0
Keck School of Medicine (EJ, University of Southern California
Career Start Year 1983
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1981
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 1980
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1979
Number of shared co-authors 1
Yale School of Medicine, Yale University
Career Start Year 1977
Number of shared co-authors 1
University of California Irvine
Career Start Year 1977
Number of shared co-authors 2
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1971
Number of shared co-authors 0
Stanford University School of Medicine, Stanford University
Career Start Year 1970
Number of shared co-authors 0

Collaborators

University of California San Diego School of Medicine, and Clinical Center
Co-authored papers 33
University of California
Co-authored papers 23
Colorado State University
Co-authored papers 18
University of California San Diego School of Medicine, and Clinical Center
Co-authored papers 18
University of California San Diego School of Medicine
Co-authored papers 7
University of California
Co-authored papers 3
University of Pennsylvania Perelman School of Medicine
Co-authored papers 2
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
Alfred P. Sloan Foundation, National Academy of Sciences, University of California Berkeley, University of California San Diego, University of California, San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1